It is of note that HER2+ in Table 2 defines a positive HER2 amplification, while HER2-enriched represents the estrogen receptor-negative (ER−), progesteron receptor-negative (PR−), HER2+ molecular subtype of breast cancer [21]. This evidence concerns the gene ESR1 and breast carcinoma.